These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23129172)

  • 1. Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease.
    Siddappa CM; Watson MA; Pillai SG; Trinkaus K; Fleming T; Aft R
    Breast Cancer Res Treat; 2013 Jan; 137(1):45-56. PubMed ID: 23129172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.
    Siddappa CM; Pillai SG; Snider J; Alldredge P; Trinkaus K; Watson MA; Aft R
    Breast Cancer Res Treat; 2019 Nov; 178(2):317-325. PubMed ID: 31432366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.
    Pillai SG; Li S; Siddappa CM; Ellis MJ; Watson MA; Aft R
    Breast Cancer Res; 2018 Jan; 20(1):2. PubMed ID: 29291741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients.
    Gilje B; Nordgård O; Tjensvoll K; Borgen E; Synnestvedt M; Smaaland R; Naume B
    BMC Cancer; 2014 Jul; 14():514. PubMed ID: 25023626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients.
    Borgen E; Rypdal MC; Sosa MS; Renolen A; Schlichting E; Lønning PE; Synnestvedt M; Aguirre-Ghiso JA; Naume B
    Breast Cancer Res; 2018 Oct; 20(1):120. PubMed ID: 30322396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paired-like Homeodomain Transcription factor 2 expression by breast cancer bone marrow disseminated tumor cells is associated with early recurrent disease development.
    Pillai SG; Dasgupta N; Siddappa CM; Watson MA; Fleming T; Trinkaus K; Aft R
    Breast Cancer Res Treat; 2015 Oct; 153(3):507-17. PubMed ID: 26400846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
    Fehm T; Hoffmann O; Aktas B; Becker S; Solomayer EF; Wallwiener D; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res; 2009; 11(4):R59. PubMed ID: 19664291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
    Valladares-Ayerbes M; Iglesias-Díaz P; Díaz-Prado S; Ayude D; Medina V; Haz M; Reboredo M; Antolín S; Calvo L; Antón-Aparicio LM
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1185-95. PubMed ID: 19221791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases.
    Talaat IM; Hachim MY; Hachim IY; Ibrahim RAE; Ahmed MAER; Tayel HY
    Sci Rep; 2020 Aug; 10(1):13061. PubMed ID: 32747636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.
    Benoy IH; Elst H; Van der Auwera I; Van Laere S; van Dam P; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Br J Cancer; 2004 Nov; 91(10):1813-20. PubMed ID: 15505629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer.
    Cackowski FC; Wang Y; Decker JT; Sifuentes C; Weindorf S; Jung Y; Wang Y; Decker AM; Yumoto K; Szerlip N; Buttitta L; Pienta KJ; Morgan TM; Taichman RS
    Prostate; 2019 Oct; 79(14):1715-1727. PubMed ID: 31449673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse.
    Hartkopf AD; Banys M; Meier-Stiegen F; Hahn M; Röhm C; Hoffmann J; Helms G; Taran FA; Wallwiener M; Walter C; Neubauer H; Wallwiener D; Fehm T
    Breast Cancer Res Treat; 2013 Apr; 138(2):509-17. PubMed ID: 23494674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
    Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
    J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
    Rack B; Zombirt E; Trapp E; Jückstock J; Andergassen U; Neugebauer J; Kost B; Weissenbacher T; Jeschke U; Schindlbeck C; Janni W; Alunni-Fabbroni M
    Oncology; 2016; 90(4):232-8. PubMed ID: 26937631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome.
    Tjensvoll K; Oltedal S; Heikkilä R; Kvaløy JT; Gilje B; Reuben JM; Smaaland R; Nordgård O
    BMC Cancer; 2012 May; 12():190. PubMed ID: 22640166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration.
    Pillai SG; Zhu P; Siddappa CM; Adams DL; Li S; Makarova OV; Amstutz P; Nunley R; Tang CM; Watson MA; Aft RL
    PLoS One; 2017; 12(1):e0170761. PubMed ID: 28129357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.
    Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Corominas-Faja B; Urruticoechea A; Martin-Castillo B; Menendez JA
    Oncotarget; 2012 Dec; 3(12):1600-14. PubMed ID: 23307622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
    Fehm T; Banys M; Rack B; Janni W; Marth C; Blassl C; Hartkopf A; Trope C; Kimmig R; Krawczyk N; Wallwiener D; Wimberger P; Kasimir-Bauer S
    Int J Gynecol Cancer; 2013 Jun; 23(5):839-45. PubMed ID: 23694981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.